93 7336 93 7336 (Topiramate (sprinkle) 25 mg)
Pill imprint 93 7336 93 7336 has been identified as Topiramate (sprinkle) 25 mg.
Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; bipolar disorder; vulvodynia (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 93 7336 93 7336
- 25 mg
- 19.00 mm
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
- ferrosoferric oxide
ethylcellulose (7 mPa.s)
polyethylene glycol 6000
More about topiramate
- Topiramate extended-release capsules
- Topiramate sprinkle capsules
- Topiramate (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.